Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs EVRG✓SelectedUSD · EVRGGSK vs EVRG performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs EVRG

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,742.6%
EVRG return
+2,261.5%
Excess return
-518.9%
Maximum drawdown
-55.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioEVRGExcessAlpha
1D+0.5%+0.6%-0.1%+0.4%
7D+1.1%+1.4%-0.3%+0.7%
30D+6.3%+7.4%-1.1%+4.2%
3M+1.8%+7.2%-5.4%-0.2%
6M+1.7%+9.5%-7.8%-1.0%
YTD+6.5%+25.6%-19.0%-0.3%
1Y+9.5%+20.4%-10.9%+3.7%
3Y+65.3%+108.8%-43.5%+33.5%
5Y+43.7%+68.0%-24.2%+22.1%
10Y+104.1%+124.6%-20.5%+55.2%
All+1,742.6%+2,261.5%-518.9%+518.0%

Cumulative growth

Daily Returns

Daily percentage return beside EVRG.

Daily Out/Under-Performance

Portfolio return minus EVRG return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EVRG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded EVRG wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling